The expression of estrogen and progesterone receptor (ER, PR), human epidermal growth factor receptor 2 (HER2) and KI67 are determinant for BC prognosis and treatment (Perou et al, 2000; Cheang et al, 2009). This evidence concerns the gene ERBB2 and breast cancer.